glp 1 agonist india Rybelsus 14 Mg (Antidiabetics, Glucagon-Like Peptide-1 Agonists), Packaging Size: 1*10 at ₹ 3483/stripe in Nagpur Press Release Page | Press
Description
GLP-1 drugs could rapidly evolve beyond current use as diabetes and weight loss medications, with new research pointing to potential benefits in cancer, ageing, addiction, osteoarthritis and heart health

Eli Lilly and Novo Nordisk are closing in on deals with the Trump administration that would exchange deep discounts on their weight loss drugs for coverage under Medicare, per Endpoints News
Learn about GLP-1 agonists, what they can help treat, and how they work to promote weight loss
)
The glp-1 agonists market is expected to reach US$ 118,926.1 billion by 2032, growing at a significant CAGR of 18.1% from 2026 to 2032.